[1]
|
Lan, T., Li, H., Zhang, D., Xu, L., Liu, H., Hao, X., et al. (2019) KIAA1429 Contributes to Liver Cancer Progression through N6-Methyladenosine-Dependent Post-Transcriptional Modification of GATA3. Molecular Cancer, 18, Article No. 186. https://doi.org/10.1186/s12943-019-1106-z
|
[2]
|
He, P.C. and He, C. (2021) m6A RNA Methylation: From Mechanisms to Therapeutic Potential. The EMBO Journal, 40, e105977. https://doi.org/10.15252/embj.2020105977
|
[3]
|
Chen, X., Zhang, J. and Zhu, J. (2019) The Role of m6A RNA Methylation in Human Cancer. Molecular Cancer, 18, Article No. 103. https://doi.org/10.1186/s12943-019-1033-z
|
[4]
|
Ouna, B.A., Stewart, M., Helbig, C. and Clayton, C. (2012) The Trypanosoma Brucei CCCH Zinc Finger Proteins ZC3H12 and ZC3H13. Molecular and Biochemical Parasitology, 183, 184-188. https://doi.org/10.1016/j.molbiopara.2012.02.006
|
[5]
|
Wen, J., Lv, R., Ma, H., Shen, H., He, C., Wang, J., et al. (2018) ZC3H13 Regulates Nuclear RNA m6A Methylation and Mouse Embryonic Stem Cell Self-Renewal. Molecular Cell, 69, 1028-1038.e6. https://doi.org/10.1016/j.molcel.2018.02.015
|
[6]
|
Chow, R.D., Guzman, C.D., Wang, G., Schmidt, F., Youngblood, M.W., Ye, L., et al. (2017) AAV-Mediated Direct in Vivo CRISPR Screen Identifies Functional Suppressors in Glioblastoma. Nature Neuroscience, 20, 1329-1341. https://doi.org/10.1038/nn.4620
|
[7]
|
Gong, P., Shao, Y., Yang, Y., Song, W., He, X., Zeng, Y., et al. (2020) Analysis of N6-Methyladenosine Methyltransferase Reveals METTL14 and ZC3H13 as Tumor Suppressor Genes in Breast Cancer. Frontiers in Oncology, 10, Article 578963. https://doi.org/10.3389/fonc.2020.578963
|
[8]
|
Hou, J., Shan, H., Zhang, Y., Fan, Y. and Wu, B. (2020) m6A RNA Methylation Regulators Have Prognostic Value in Papillary Thyroid Carcinoma. American Journal of Otolaryngology, 41, Article ID: 102547. https://doi.org/10.1016/j.amjoto.2020.102547
|
[9]
|
Xie, R., Chen, W., Lv, Y., Xu, D., Huang, D., Zhou, T., et al. (2023) Overexpressed ZC3H13 Suppresses Papillary Thyroid Carcinoma Growth through m6A Modification-Mediated IQGAP1 Degradation. Journal of the Formosan Medical Association, 122, 738-746. https://doi.org/10.1016/j.jfma.2022.12.019
|
[10]
|
Paramasivam, A., George, R. and Priyadharsini, J.V. (2021) Genomic and Transcriptomic Alterations in m6A Regulatory Genes Are Associated with Tumorigenesis and Poor Prognosis in Head and Neck Squamous Cell Carcinoma. American Journal of Cancer Research, 11, 3688-3697.
|
[11]
|
Huang, L., Chen, G., He, J. and Wang, P. (2023) ZC3H13 Reduced Duox1-Mediated Ferroptosis in Laryngeal Squamous Cell Carcinoma Cells through m6A-Dependent Modification. Tissue and Cell, 84, Article ID: 102187. https://doi.org/10.1016/j.tice.2023.102187
|
[12]
|
Li, F., Wang, H., Huang, H., Zhang, L., Wang, D. and Wan, Y. (2020) m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma. Frontiers in Genetics, 11, Article 994. https://doi.org/10.3389/fgene.2020.00994
|
[13]
|
Wang, S., Zou, X., Chen, Y., Cho, W.C. and Zhou, X. (2021) Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer. Frontiers in Genetics, 11, Article 580036. https://doi.org/10.3389/fgene.2020.580036
|
[14]
|
Zhang, B., Gu, Y. and Jiang, G. (2020) Expression and Prognostic Characteristics of M6 a RNA Methylation Regulators in Breast Cancer. Frontiers in Genetics, 11, Article 604597. https://doi.org/10.3389/fgene.2020.604597
|
[15]
|
Fang, K., Qu, H., Wang, J., Tang, D., Yan, C., Ma, J., et al. (2021) Characterization of Modification Patterns, Biological Function, Clinical Implication, and Immune Microenvironment Association of m6A Regulators in Pancreatic Cancer. Frontiers in Genetics, 12, Article 702072. https://doi.org/10.3389/fgene.2021.702072
|
[16]
|
Huang, C., Zhou, S., Zhang, C., Jin, Y., Xu, G., Zhou, L., et al. (2022) Zc3h13-mediated N6-Methyladenosine Modification of PHF10 Is Impaired by Fisetin Which Inhibits the DNA Damage Response in Pancreatic Cancer. Cancer Letters, 530, 16-28. https://doi.org/10.1016/j.canlet.2022.01.013
|
[17]
|
Li, L., Xie, R. and Wei, Q. (2021) Network Analysis of Mirna Targeting m6A-Related Genes in Patients with Esophageal Cancer. PeerJ, 9, e11893. https://doi.org/10.7717/peerj.11893
|
[18]
|
Huang, Y., Chen, S., Qin, W., Wang, Y., Li, L., Li, Q., et al. (2020) A Novel RNA Binding Protein-Related Prognostic Signature for Hepatocellular Carcinoma. Frontiers in Oncology, 10, Article 580513. https://doi.org/10.3389/fonc.2020.580513
|
[19]
|
Kong, F., Wang, K. and Wang, L. (2022) Systematic Analysis of the Expression Profile and Prognostic Significance of m6A Regulators and PD-L1 in Hepatocellular Carcinoma. Discover Oncology, 13, Article No. 131. https://doi.org/10.1007/s12672-022-00595-x
|
[20]
|
Shi, Y., Wang, Y., Zhang, W., Niu, K., Mao, X., Feng, K., et al. (2023) N6-methyladenosine with Immune Infiltration and PD-L1 in Hepatocellular Carcinoma: Novel Perspective to Personalized Diagnosis and Treatment. Frontiers in Endocrinology, 14, Article 1153802. https://doi.org/10.3389/fendo.2023.1153802
|
[21]
|
Li, D., Li, K., Zhang, W., Yang, K., Mu, D., Jiang, G., et al. (2022) The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates with the Immune Status of Hepatocellular Carcinoma. Frontiers in Immunology, 13, Article 918140. https://doi.org/10.3389/fimmu.2022.918140
|
[22]
|
Kim, Y.R., Chung, N.G., Kang, M.R., et al. (2010) Novel Somatic Frameshift Mutations of Genes Related to Cell Cycle and DNA Damage Response in Gastric and Colorectal Cancers with Microsatellite Instability. Tumori Journal, 96, 1004-1009.
|
[23]
|
Yang, J., Wu, Z., Wu, X., Chen, S., Xia, X. and Zeng, J. (2022) Constructing and Validating of m6a-Related Genes Prognostic Signature for Stomach Adenocarcinoma and Immune Infiltration: Potential Biomarkers for Predicting the Overall Survival. Frontiers in Oncology, 12, Article 1050288. https://doi.org/10.3389/fonc.2022.1050288
|
[24]
|
Zhu, D., Zhou, J., Zhao, J., Jiang, G., Zhang, X., Zhang, Y., et al. (2018) ZC3H13 Suppresses Colorectal Cancer Proliferation and Invasion via Inactivating Ra-ERK Signaling. Journal of Cellular Physiology, 234, 8899-8907. https://doi.org/10.1002/jcp.27551
|
[25]
|
Kang, J., Xiang, X., Chen, X., Jiang, J., Zhang, Y., Li, L., et al. (2023) Angiogenesis-Related Gene Signatures Reveal the Prognosis of Cervical Cancer Based on Single Cell Sequencing and Co-Expression Network Analysis. Frontiers in Cell and Developmental Biology, 10, Article 1086835. https://doi.org/10.3389/fcell.2022.1086835
|
[26]
|
Zhang, Y., Chen, X., Chen, H. and Zhang, Y. (2023) ZC3H13 Enhances the Malignancy of Cervical Cancer by Regulating m6A Modification of CKAP2. Critical Reviews in Immunology, 43, 1-13. https://doi.org/10.1615/critrevimmunol.2023049342
|
[27]
|
Pan, J., Xu, L. and Pan, H. (2020) Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma. Frontiers in Oncology, 10, Article 1444. https://doi.org/10.3389/fonc.2020.01444
|
[28]
|
Ma, J., Yang, D. and Ma, X. (2021) Immune Infiltration-Related N6-Methyladenosine RNA Methylation Regulators Influence the Malignancy and Prognosis of Endometrial Cancer. Aging, 13, 16287-16315. https://doi.org/10.18632/aging.203157
|
[29]
|
Fan, L., Lin, Y., Lei, H., Shu, G., He, L., Yan, Z., et al. (2020) A Newly Defined Risk Signature, Consisting of Three m6A RNA Methylation Regulators, Predicts the Prognosis of Ovarian Cancer. Aging, 12, 18453-18475. https://doi.org/10.18632/aging.103811
|
[30]
|
Liu, Z., Zhong, J., Zeng, J., Duan, X., Lu, J., Sun, X., et al. (2021) Characterization of the m6A-Associated Tumor Immune Microenvironment in Prostate Cancer to Aid Immunotherapy. Frontiers in Immunology, 12, Article 735170. https://doi.org/10.3389/fimmu.2021.735170
|
[31]
|
Ding, D., Liu, G., Gao, J. and Cao, M. (2022) Unveiling the m6A Methylation Regulator Links between Prostate Cancer and Periodontitis by Transcriptomic Analysis. Disease Markers, 2022, Article ID: 4030046. https://doi.org/10.1155/2022/4030046
|
[32]
|
Feng, D., Wang, J., Li, D., Wu, R., Wei, W. and Zhang, C. (2023) Senescence-Associated Secretory Phenotype Constructed Detrimental and Beneficial Subtypes and Prognostic Index for Prostate Cancer Patients Undergoing Radical Prostatectomy. Discover Oncology, 14, Article No. 155. https://doi.org/10.1007/s12672-023-00777-1
|
[33]
|
Yang, Z., Luo, Y., Zhang, F. and Ma, L. (2024) Exosome-Derived IncRNA A1BG-AS1 Attenuates the Progression of Prostate Cancer Depending on ZC3H13-Mediated m6A Modification. Cell Division, 19, Article No. 5. https://doi.org/10.1186/s13008-024-00110-4
|
[34]
|
Chen, J., Yu, K., Zhong, G. and Shen, W. (2020) Identification of a m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Clear Cell Renal Carcinoma. Cancer Cell International, 20, Article No. 157. https://doi.org/10.1186/s12935-020-01238-3
|
[35]
|
Guo, T., Duan, H., Chen, J., Liu, J., Othmane, B., Hu, J., et al. (2021) N6-Methyladenosine Writer Gene ZC3H13 Predicts Immune Phenotype and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma. Frontiers in Oncology, 11, Article 718644. https://doi.org/10.3389/fonc.2021.718644
|
[36]
|
Trilla-Fuertes, L., Ghanem, I., Maurel, J., G-Pastrián, L., Mendiola, M., Peña, C., et al. (2020) Comprehensive Characterization of the Mutational Landscape in Localized Anal Squamous Cell Carcinoma. Translational Oncology, 13, Article ID: 100778. https://doi.org/10.1016/j.tranon.2020.100778
|
[37]
|
Parameswaran, S., Vizeacoumar, F.S., Kalyanasundaram Bhanumathy, K., Qin, F., Islam, M.F., Toosi, B.M., et al. (2018) Molecular Characterization of an MLL1 Fusion and Its Role in Chromosomal Instability. Molecular Oncology, 13, 422-440. https://doi.org/10.1002/1878-0261.12423
|
[38]
|
Hou, M., Guo, X., Chen, Y., Cong, L. and Pan, C. (2020) A Prognostic Molecular Signature of N⁶-Methyladenosine Methylation Regulators for Soft-Tissue Sarcoma from the Cancer Genome Atlas Database. Medical Science Monitor, 26, e928400. https://doi.org/10.12659/msm.928400
|